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ABSTRACT
Objectives: To assess the clinical value and treatment outcomes of postoperative methotrexate (MTX) therapy in the 
management of early abdominal pregnancy. 
Material and methods: We retrospectively analyzed ten (10) cases of early abdominal pregnancy at our hospital between 
7th August, 2006 and 20th April, 2017. 
Results: Out of the ten (10) cases identified, six (6) patients and four (4) patients underwent surgery (laparotomy or lapa-
roscopy) only and surgery (laparotomy or laparoscopy) plus IM 50 mg/m2 methotrexate (MTX) within 24 hours of surgery 
respectively. The gestation age and serum β-HcG levels were significantly lower (p < 0.05, 6.0 ± 1.82 and 8073.2 ± 9561.0) 
in the surgery plus MTX group in comparison to (7.33 ± 3.61 and 15625 ± 21275.2) for the surgery only group. Ultrasound 
imaging findings reported extra uterine pregnancy in all cases and diagnostic surgery was necessary to locate precise site 
of implantation to plan further treatment. Days of hospitalization were shorter in the surgery + MTX group than in the 
surgery only group (3.00 ± 0.816 versus 5.66 ± 2.80).
Conclusions: Earliness in diagnosis coupled with the appropriate (methotrexate) MTX regime could help prevent unwanted 
complications that could arise from delayed or misdiagnosis. 
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INTRODUCTION
Abdominal ectopic pregnancies (AEP) are the rarest form 
ectopic pregnancies. With an estimated incidence of 1/6000 to 
1/9000 births and 1/2200 to 1/10200 pregnancies, their mor-
tality rate is reported to be 7.7 times and 89.8 times higher in 
tubal pregnancy and intrauterine pregnancy respectively [1, 2]. 
They can be referred to as; early when gestation is at or be-
fore 20 weeks and late when gestation is after 20 weeks [3]. 
Although rarely used clinically, signs and symptoms, levels of se-
rum beta human chorionic gonadotrophin (ß-hCG), ultrasound 
and magnetic resonance imaging can be diagnostically pro-
ductive in certain instances [4, 5]. Diagnostic laparoscopy has 
become the cornerstone treatment for AEP, but they can also be 
managed medically with systemic or local methotrexate (MTX), 
ultrasound guided potassium chloride (KCL), danazol and mife-
pristone [6, 7]. While few cases of early abdominal cases have 
been managed with surgery plus methotrexate, no studies, 
according to our knowledge have investigated the importance 
of methotrexate in these scenarios [8, 9]. We retrospectively 
studied the records of ten (10) who were diagnosed with early 
abdominal pregnancy in our hospital and were managed with 
surgery alone or surgery plus MTX. This study was necessary 
because, an in-depth understanding of the presentation, diag-
nosis and management of this rare form of ectopic pregnancy 
would help to minimize cases of late or misdiagnosis which 
could result in loss of fertility or even maternal mortality [10].
MATERIAL AND METHODS
A single institution retrospective study was carried out 
between 7th August, 2006 and 20th April, 2017 at the First 
Affiliated Hospital of Wenzhou Medical University, Zhejiang 
Province, China where ten (10) cases of early abdominal preg-
nancies were identified. Information on patient’s biodata, 
pregnancy history, presenting features and reproductive out-
comes were retrieved from our computerized medical chart as 
documented by three different surgeons who oversaw their 
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management. Although high titers of serum ß-HCG prompted 
the suspicion of ectopic pregnancy, the definitive diagnosis of 
early abdominal pregnancy (before 20 weeks gestation) was 
made based on perioperative findings at varying implantation 
sites and was later confirmed by pathological examination. 
Cases of tubal pregnancies and pregnancies at locations that 
do not fit the criteria of early abdominal pregnancy and preg-
nancy beyond 20 weeks gestation were all excluded. Permis-
sion to carry on with this study was granted after careful evalu-
ation by the Ethics Committee of The First Affiliated Hospital 
of Wenzhou Medical University (wydw2017–0115) and after 
patients gave their verbal consent through telephone calls. We 
subsequently divided the 10 cases into two main categories 
depending on the treatment modalities each patient received 
as surgery only and surgery plus IM 50 mg/m2 methotrexate 
(MTX). Details on maternal age, pregnancy history, gestational 
age, presenting symptoms, pre and post-operative blood 
levels of beta human chorionic gonadotropin (ß-hCG), im-
plantation sites, first and second lines of treatment, blood loss, 
days of hospitalization and reproductive outcomes were all 
documented. Amount of blood loss during laparoscopy was 
evaluated from the suction-irrigation tube and from direct 
suction combined with the weight of soaked pads during lapa-
rotomy. Presenting symptoms among the patients included 
abdominal pain and vaginal bleeding. Statistical calculations 
were done using independent sample t-test, where significant 
differences between the two groups were deemed at p < 0.05.
RESULTS
Clinical characteristics of the participants
The comprehensive information on all the ten (10) cas-
es of primary abdominal pregnancies is shown in Table 1. 
The mean ± SD for age was 29.9 ± 5.93 years while the ges-
tational age as estimation by last menstrual period (LMP) 
was 6.8 ± 2.973 weeks. The median gravidity and parity 
was 2 (range 1–3) and 1 (range 1–3) respectively. Risk fac-
tors recorded include previous pelvic inflammatory disease 
(2 of 10, 20%), history of In Vitro Fertilization (3 of 10, 30%), 
previous tubal surgery (3 of 10, 30%) and two (2 of 10, 
20%) patients with no existing factors.  In all the 10 cases, 
4 patients presented with complaints of vaginal bleeding 
and abdominal pain, 5 with only abdominal pain and only 
one with vaginal bleeding. Case 8 reported with the highest 
level of serum ß-hCG of 58121 Iu/L. Details of the report on 
preoperative ultrasonographic findings are summarized in 
Table 2. Only three cases were managed with laparotomy, 
the remaining seven cases (2010–2017) were all managed 
laparoscopically. Varied sites of implantation reported in-
clude pouch of Douglas (3 of 10, 30%), mesosalpinx (3 of 
10, 30%), vesicouterine pouch (2 of 10, 20%), intestinal wall 
(1 of 10, 10 %) and omentum (1 of 10, 10 %).  Only 4 pa-
tients (Case 5, 6, 7, 9) received a second line treatment of 
IM 50 mg/m2 methotrexate (MTX) within 24-hours of sur-
gery. The overall mean ± SD for days of hospitalization was 
4.6 ± 2.547 days with Case 1 staying the longest (11 days). 
Four patients were lost to follow up, but two (case 5 and 6) 
out of the six patients we contacted in 2017 had achieved 
spontaneous delivery at 4 and 2 years respectively follow-
ing their treatment.
Pre and post-operative serial measurement of 
serum ß-hCG
Graphical representation of serum ß-hCG levels on the 
first day of admission (Day 0) and throughout the course 
Table 1. Patient characteristics
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Weeks 
of GA Symptoms
Serum β-HCG 
level (Iu/L)
Implantation 
site
Treatment
Days In 
hospital
Reproductive 
outcome
1st TX. 2nd TX.
1 2006 33 G2P0 Previous TS 13 AP 6,414 Mesosalpinx LAP _ 11 No delivery
2 2006 32 G3P2 Previous TS 7 VB+AP 11,705 POD LAP _ 5 Post TL
3 2008 27 G1P1 PID 5 VB+AP 12,048 Mesosalpinx LAP _ 3 –
4 2010 32 G2P1 None 6 VB 307 Intestinal wall LSC _ 4 –
5 2011 25 G1P1 PID 7 AP 20,731 POD LSC MTX 3 1 SD, after 4 years
6 2013 27 G2P1 None 8 VB+AP 512 VUP LSC MTX 4 1 SD, after 2 years
7 2014 18 G1P0 IVF 5 VB+AP 842 Mesosalpinx LSC MTX 3 –
8 2015 37 G2P1 Previous TS 10 AP 58,121 POD LSC _ 6 –
9 2017 30 G0P0 IVF 4 AP 10,208 Omentum LSC MTX 2 Infertility History
10 2017 38 G0P0 IVF 3 AP 5,155 VUP LSC _ 5 Infertility History
AP — abdominal pain; G — gravidity; GA — gestational age; IVF — in vitro fertilization; LAP — laparotomy; LSC — laparoscopy; MTX — methotrexate; P — parity; 
PID — pelvic inflammatory disease; POD — pouch of Douglas; SD — spontaneous delivery; TL — tubal ligation; TS — tubal surgery; TX — treatment; VB — vaginal 
bleeding; VUP — vesico-uterine pouch
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of treatment (Post-operative Day 1–6) is shown in Figure 
1. Case 8 and Case 4 recorded the highest (58121 Iu/L) and 
the lowest (307 Iu/L) levels of serum ß-hCG respectively. 
Levels of serum ß-hCG were also assessed on 1st, 2nd, 3rd, 
4th, 5th and 6th post-operative days. All patients displayed 
a sharp decline in their levels on the first day after surgery. 
However cases 2, 9, 10 showed a slight upsurge in their levels 
on post-operative day 2 but not as high as the levels on the 
day of admission (Day 0). Serum ß-hCG levels continued to 
plummet from post-operative day 3 through to 6th operative 
day except for case 10 that showed an obvious fluctuating 
trend throughout the course of treatment.
Correlation between treatment modalities and 
clinical parameters
The surgery plus methotrexate group presented with 
a mean gestational age of 6.0 ± 1.82 vs the 7.33 ± 3.61 among 
the surgery only group with a significant difference 
(p = 0.000049). The surgery only group recorded more 
number of abortions than the surgery plus methotrexate 
group. Levels of serum ß-hCG on the day of admission 
were significantly correlated and higher in the surgery 
only group that (15625  ±  21275.2 vs 8073.2  ±  9561.00, 
p = 0.046065. Further successive measurements of serum 
ß-hCG throughout the course of therapy and on the day 
of discharge demonstrated that the group that was man-
aged with surgery and methotrexate had lower levels of 
serum ß-hCG in comparison to the group that had under-
gone surgery only (1071.4 ± 1269.11 vs 5935.66 ± 4378.6, 
p = 0.01824). The two groups were significantly correlated 
in terms of length of hospital stay (p < 0.05). The surgery 
plus methotrexate group were discharged from hospital 
much earlier than the group who received surgery only 
(3.00 ± 0.816 vs 5.66 ± 2.80) Table 3.
DISCUSSION
From a select population of 8,547 ectopic pregnancies 
diagnosed in our institution between 7th August, 2006 and 
20th April, 2017, only 10 (0.11%) cases were diagnosed and 
treated as early abdominal pregnancy representing the 
least form of ectopic pregnancy in our institution. Endo-
Table 2. Transvaginal ultrasound imaging characteristics
Case Radiologic comments
1 A cystic mass shadow measuring 16 × 10 × 13 mm in the posterior wall of uterus + pelvic fluid
2 Gestation sac consistent with 6 weeks in the pouch of Douglas + free peritoneal fluid 
3 A heterogenous mass 29 × 19 × 18 mm near the left ovary + suspected bleeding in the pouch of Douglas
4 A 21 × 29 × 42 mm cystic area + pelvic fluid with internal echoes
5 Free fluid in the lower abdomen + pelvic solid mass in the pouch of Douglas
6 A 22 × 17 mm vital embryo + cardiac activity in the pouch of Douglas 
7 A possible extra-uterine (right side of the uterus) with an empty uterus and normal adnexa
8 A hyperechogenic mass (20 × 27 × 23 mm) behind the uterus on the left side + pelvic fluid
9 No intrauterine gestational sac + possible hemantoma (43 × 28 × 31 mm) close to the left ovary
10 Mass-like area measuring 27 × 36 × 34 mm + fluid in the anterior and posterior cul-de-sacs
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Figure 1. Serial measurement of serum ß-hCG. Day 0 represents 
the first day of admission and days 1, 2, 3, 4, 5 and 6 represent post-
operative days
Table 3: Management of primary abdominal pregnancy: surgery 
only vs surgery plus methotrexate (MTX)
Variables
Group 1: 
SURGERY ONLY
(mean ± SD)
Group 2: 
SURGERY + MTX
(mean ± SD)
Number of Cases 6 4
Gestational Age (weeks) 7.33 ± 3.61 6.0 ± 1.82
Day 0: Serum β-HcG Level (Iu/L) 15625 ± 21275.2 8073.2 ± 9561.0
Day1-6: Serum β-HcG Level (Iu/L)
Intra-operative blood loss (mL)
5935.66 ± 4378.6
1370 ± 1909.9
1071.4 ± 1269.11
625 ± 330.4
Number of abortions 1.666 ± 1.63 0.50 ± 0.57
Days of hospitalization 5.66 ± 2.80 3.00 ± 0.816
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metriosis, the current usage of an intrauterine device and 
a history of tubal surgery or ectopic pregnancy are some of 
the documented risk factors for abdominal pregnancy and 
also implicated in other forms of ectopic pregnancies [11]. 
The sites of implantation from the commonest to the least 
reported include the pouch of Douglas (pouches surround-
ing the uterus), uterine serosa and adnexa, abdominal or-
gans, omentum, bowel/appendix, liver (common site is 
the right lobe), spleen, retroperitoneal and the wall of the 
abdomen. Similar implantation locations were discovered 
in this present study. All cases indexed in this study met 
the established criteria for primary abdominal pregnancy: 
(1) normal ovaries and tubes with no evidence of injury, 
(2) no evidence of uteroplacental fistula, and (3) the preg-
nancy is adhered exclusively to the peritoneal surface early 
enough in gestation to eliminate the possibility of secondary 
implantation after primary nidation in the fallopian tube [12].
The diagnosis of early abdominal pregnancy is a huge 
clinical hurdle as most of the investigative tools are some-
times unreliable. Presenting symptoms are not strong diag-
nostic tools due to the absence of typical pathognomonic 
symptoms to properly define early abdominal pregnancy. 
Additionally, due to the upsurge of serum ß-hCG levels in 
other forms ectopic pregnancies and the difficulty associ-
ated with singling out early abdominal pregnancy based on 
ultrasonographic features, these investigations are not very 
instrumental in diagnosis as well [4, 5, 13]. In this present 
study, diagnostic surgery was the first line option due to the 
worsening nature of their symptoms and our high suspicion 
of ectopic rupture. We proceeded quickly with either diag-
nostic laparotomy or laparoscopy to avert any mortalities or 
complications and to also aid in the formulation of a better 
post-operative treatment regime. Until recently, laparotomy 
was the conventional surgical approach but several reports 
have exhibited the novelty of diagnostic laparoscopic ap-
proach in early abdominal pregnancy management [9, 14]. 
In one study to compare the treatment outcomes of these 
two modalities in abdominal pregnancies, it was observed 
that, with advancement in technology and improved surgi-
cal skills more cases can be confidently managed laparo-
scopically. The authors also reported varying advantages 
of management with laparoscopy ranging from reduced 
blood loss to short hospital stay [15].
Diagnostic laparoscopy was carried out uneventfully and 
peri-operative findings included normal uterus and adnexa 
in all cases, hemoperitoneum of about 250cc and 320cc for 
cases 3 and 9 respectively and were transfused with 2 units of 
whole blood and 3 units of packed red blood cells respectively 
during surgery. Further examination of the abdomen revealed 
bloody lesions that were loosely or tenaciously adhered to 
varying locations in the abdomen. These lesions were re-
moved with the help of non-traumatic laparoscopic forceps 
and bipolar scissors. In all laparoscopic cases, we achieved 
hemostasis with the help of bipolar coagulation ruling out the 
need for suturing. Laparotomy was successfully carried out 
on three patients (Case 1, 2, 3) but factors that necessitated 
this choice of management were not recorded. Clinically, the 
decision to opt for laparotomy can be decided on factors like 
the anatomical position of the pregnancy or the laparoscopic 
skills and confidence of the surgeon [16]. Because of the 
likelihood of implantation on vascularized surfaces which 
may have high propensity to separate at any time to cause 
heavy bleeding, the decision between these two manage-
ment modalities should be precise and prompt [17].
Methotrexate (MTX) has proven to be an effective agent 
in managing ectopic pregnancy medically since its introduc-
tion in 1982 [18]. Its effectiveness has been likened to sur-
gery in terms of treatment results and preservation of future 
fertility [19, 20]. Successful treatment which meant avoid-
ance of surgery was recorded to be 94.4% in women with ini-
tial β-hCG levels of 1000 to 1999 mIU/mL and 81.8% in their 
counterparts with levels from 10,000 to 150,000 mIU/mL. 
In early abdominal pregnancy, however, there is a high prob-
ability of reverting to surgical management among patients 
who receive systemic or local injections of MTX as first line 
therapy [6, 13, 21]. The decision for the use of post-operative 
MTX in ectopic pregnancy include cases were, potential 
life-threatening torrential bleeding can be foreseen or when 
there is an upswing or a less than 20% drop in the levels of 
serum ß-hCG measured consecutively on 3 days apart or 
prophylactically when incomplete resection or persistent 
ectopic pregnancy is likely  [22, 23]. By virtue of the position 
of their lesions on highly vascularized organs and presence 
of hemoperitoneum which was suggestive of rupture, the 
surgeons advised the use of methotrexate (MTX) in Case 
5, 6 and 7. On the other hand, Case 9 received methotrex-
ate (MTX) because the clinicians suspected persistence of 
her pregnancy which was evidenced by upsurge in her 
serum HCG levels on post-operative day 2. Although, cases 
2, 8 and 10 witnessed fluctuations in their serum HCG levels 
post-operatively to also permit the use of MTX, contra-in-
dicatory factors like existing peptic ulcer (Case 2), hemo-
dynamic instability (Case 8) and non-compliance (Case 10) 
did not make them good candidates [24]. Regarding treat-
ment outcomes, we cannot confidently draw any valid in-
ference from post-operative serum levels among the two 
groups. The gestational ages and the pre-operative HCG 
levels were lower in the surgery + MTX group in comparison 
to the surgery only group and therefore it is likely the reason 
why their serum ß-HCG levels on hospital discharge were 
lower. Additionally, the reduced blood loss among the sur-
gery + MTX group could also account for their shorter days 
of hospitalization. Data from this present study regarding 
future fertility is inconclusive, although the use of MTX is 
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reported to enhance future fertility in other forms of tubal 
ectopic pregnancy [25].
CONCLUSIONS
The rarity, complex history and atypical clinical charac-
teristics of abdominal ectopic pregnancy make its diagnosis 
and management extremely puzzling. Conservative surgery 
and medical therapy can be regarded as appropriate treat-
ment modalities but diagnostic laparoscopy has become 
the optimal choice because it ensures earliness in diag-
nosis and offers a better view of the location to determine 
the size and relative vascularity. A thorough inspection of 
the abdominal viscera should be carried out to rule out 
implantation at uncommon sites. Adjuvant MTX therapy 
can help reduce complications especially when torrential 
bleeding from vascularized sites can be anticipated but 
the selection of good candidates still remains crucial. The 
paucity of information on abdominal pregnancy retrieved 
from only case reports and series limits this study to a larger 
extent. Non-compliance from patients in this indexed study 
makes the data on serial post-operative serum ß-HCG lev-
els statistically insufficient to draw any strong conclusions 
from in terms of treatment outcomes. Further studies are 
therefore needed to adequately examine the usefulness of 
post-operative MTX clinically.
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